Literature DB >> 29730803

Paroxysmal ocular movements - an early sign in Glut1 deficiency Syndrome.

Sofia Reis1, Joana Matias2, Raquel Machado3, José Paulo Monteiro4.   

Abstract

The authors describe a 3-year-old female, diagnosed with GLUT1 deficiency Syndrome, with a previously unreported mutation in exon 7 of the SLC2A1 gene: c.968_972 + 3del P. (Val323Alafs*53), characterized by a classic phenotypic of acquired microcephaly, developmental delay, ataxia, spasticity, and epilepsy. Ketogenic diet was started at the age of 30 months with epilepsy improvement. She presented paroxysmal ocular movements in the first 12 months of life, recently defined as "aberrant gaze saccades", that are present in the early phase of visual system development, being one of the first disease signs, but easily disregarded. Recognizing these particular ocular movements would allow an early diagnosis, followed by ketogenic diet implementation, improving significantly the prognosis and the neurological development of those children.

Entities:  

Keywords:  Glut1 deficiency Syndrome; SLC2A1 gene; ketogenic diet; microcephaly; paroxysmal ocular movements

Mesh:

Substances:

Year:  2018        PMID: 29730803     DOI: 10.1007/s11011-018-0225-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

1.  GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier.

Authors:  G Seidner; M G Alvarez; J I Yeh; K R O'Driscoll; J Klepper; T S Stump; D Wang; N B Spinner; M J Birnbaum; D C De Vivo
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

2.  Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro.

Authors:  Hei Yi Wong; Tsui Shan Chu; Janice Ching Lai; Kwok Pui Fung; Tai Fai Fok; Tatsuya Fujii; Yuan Yuan Ho
Journal:  J Cell Biochem       Date:  2005-11-01       Impact factor: 4.429

3.  Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet.

Authors:  Jennifer R L Friedman; Elizabeth A Thiele; Dong Wang; Kara B Levine; Erin K Cloherty; Heidi H Pfeifer; Darryl C De Vivo; Anthony Carruthers; Marvin R Natowicz
Journal:  Mov Disord       Date:  2006-02       Impact factor: 10.338

4.  The ketogenic diet in infants--Advantages of early use.

Authors:  Anastasia Dressler; Petra Trimmel-Schwahofer; Eva Reithofer; Gudrun Gröppel; Angelika Mühlebner; Sharon Samueli; Viktoria Grabner; Klaus Abraham; Franz Benninger; Martha Feucht
Journal:  Epilepsy Res       Date:  2015-07-09       Impact factor: 3.045

5.  Long-term clinical course of Glut1 deficiency syndrome.

Authors:  Aliza S Alter; Kristin Engelstad; Veronica J Hinton; Jacqueline Montes; Toni S Pearson; Cigdem I Akman; Darryl C De Vivo
Journal:  J Child Neurol       Date:  2014-04-30       Impact factor: 1.987

6.  Glut1 deficiency syndrome and erythrocyte glucose uptake assay.

Authors:  Hong Yang; Dong Wang; Kristin Engelstad; Leslie Bagay; Ying Wei; Michael Rotstein; Vimla Aggarwal; Brynn Levy; Lijiang Ma; Wendy K Chung; Darryl C De Vivo
Journal:  Ann Neurol       Date:  2011-12       Impact factor: 10.422

7.  Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.

Authors:  David J Coman; K G Sinclair; C J Burke; D B Appleton; J T Pelekanos; C M O'Neil; G B Wallace; F G Bowling; D Wang; D C De Vivo; J J McGill
Journal:  J Paediatr Child Health       Date:  2006-05       Impact factor: 1.954

Review 8.  Glucose transporter 1 deficiency syndrome and other glycolytic defects.

Authors:  Darryl C De Vivo; Linda Leary; Dong Wang
Journal:  J Child Neurol       Date:  2002-12       Impact factor: 1.987

9.  Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.

Authors:  Dong Wang; Juan M Pascual; Hong Yang; Kristin Engelstad; Sarah Jhung; Ruo Peng Sun; Darryl C De Vivo
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

10.  Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

Authors:  Wilhelmina G Leen; Joerg Klepper; Marcel M Verbeek; Maike Leferink; Tom Hofste; Baziel G van Engelen; Ron A Wevers; Todd Arthur; Nadia Bahi-Buisson; Diana Ballhausen; Jolita Bekhof; Patrick van Bogaert; Inês Carrilho; Brigitte Chabrol; Michael P Champion; James Coldwell; Peter Clayton; Elizabeth Donner; Athanasios Evangeliou; Friedrich Ebinger; Kevin Farrell; Rob J Forsyth; Christian G E L de Goede; Stephanie Gross; Stephanie Grunewald; Hans Holthausen; Sandeep Jayawant; Katherine Lachlan; Vincent Laugel; Kathy Leppig; Ming J Lim; Grazia Mancini; Adela Della Marina; Loreto Martorell; Joe McMenamin; Marije E C Meuwissen; Helen Mundy; Nils O Nilsson; Axel Panzer; Bwee T Poll-The; Christian Rauscher; Christophe M R Rouselle; Inger Sandvig; Thomas Scheffner; Eamonn Sheridan; Neil Simpson; Parol Sykora; Richard Tomlinson; John Trounce; David Webb; Bernhard Weschke; Hans Scheffer; Michél A Willemsen
Journal:  Brain       Date:  2010-02-02       Impact factor: 13.501

View more
  1 in total

Review 1.  Clinical and Genetic Overview of Paroxysmal Movement Disorders and Episodic Ataxias.

Authors:  Giacomo Garone; Alessandro Capuano; Lorena Travaglini; Federica Graziola; Fabrizia Stregapede; Ginevra Zanni; Federico Vigevano; Enrico Bertini; Francesco Nicita
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.